Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Clemastine Enhances Myelination in the Prefrontal Cortex and Rescues Behavioral Changes in Socially Isolated Mice.
Alterations in nerve-evoked bladder contractions in a coronavirus-induced mouse model of multiple sclerosis.
Short Myelitis Lesions in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorders.
Relapse of neuromyelitis optica during pregnancy-Treatment options and literature review.
A Bayesian approach to probabilistic sensitivity analysis in structured benefit-risk assessment.
Monoclonal antibody therapy in multiple sclerosis: critical appraisal and new perspectives.
[New therapeutic options in multiple sclerosis].
Long term cardiac safety and tolerability of Fingolimod in Multiple Sclerosis: A post-marketing study.
Genetic contribution to multiple sclerosis risk among Ashkenazi Jews.
Modeling the course and outcomes of MS is statistical twaddle-No.
The cognitive reserve theory in the setting of pediatric-onset multiple sclerosis.
Time to target brain atrophy and neurodegeneration in multiple sclerosis.
Brain iron deposition in white matter hyperintensities: a 3-T MRI study.
Differential neuroprotective effects of 5'-deoxy-5'-methylthioadenosine.
Lipocalin-2 deficiency ameliorates experimental autoimmune encephalomyelitis: the pathogenic role of lipocalin-2 in the central nervous system and peripheral lymphoid tissues.
Changes of statistical structural fluctuations unveils an early compacted degraded stage of PNS myelin.
Recent advances and future challenges in the genetics of multiple sclerosis.
Interactions of innate and adaptive immunity in brain development and function.
Effects of peptide fraction and counter ion on the development of clinical signs in experimental autoimmune encephalomyelitis.
PET Imaging of Disease Progression and Treatment Effects in the Experimental Autoimmune Encephalomyelitis Rat Model.
Cerebrospinal fluid analysis in infectious diseases of the nervous system: when to ask, what to ask, what to expect.
Kynurenines and Multiple Sclerosis: The Dialogue between the Immune System and the Central Nervous System.
Exome and regulatory element sequencing of neuromyelitis optica patients.
Self-rated health in women prior to clinical onset of multiple sclerosis: A study within the Danish National Birth Cohort.
The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next Steps.
Pages
« first
‹ previous
…
606
607
608
609
610
611
612
613
614
…
next ›
last »